Prevention of Cmv Disease in Transplant Recipients
📧 Sign up to get email alerts when something new happens for Prevention of Cmv Disease in Transplant Recipients.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-06-21FDA Approved: GANCICLOVIR — Original Application (Fresenius Kabi USA, LLC)
FDA approved Fresenius Kabi USA, LLC's original application for GANCICLOVIR SODIUM (ganciclovir), marking a generic approval.